Main Business：Preclinical CRO • Large Animal Models • Device & Drug Efficacy/Safety | FDA, CE MDR, ANVISA, NMPA | OECD-GLP & AAALAC AccreditedCompany Type：Research or Consult
Operating Model：Service Providers
Size：100-499人
Capital：1500万RMB
Establishment：2019
Sell：Preclinical CRO Services | Animal Studies for Medical Devices | Drug Efficacy & Safety Evaluation | Large Animal Models | FDA 510(k) Non-clinical Support | CE MDR Preclinical Evaluation
At HuaTeng Biotechnology, we go beyond generating data — we deliver reliable, decision-ready results to support your therapeutic and diagnostic development.
We understand that successful development depends on the translational relevance of preclinical models and the quality of data submitted to global regulators. By combining clinically relevant disease models with our AAALAC-accredited and GLP-compliant platform, we help improve study reliability and accelerate R&D timelines.
Whether supporting IND-enabling studies for novel drugs or conducting preclinical evaluation for Class III medical devices, our team ensures studies are executed with consistency, scientific rigor, and regulatory awareness.
With experience from over 3,000 CRO projects and support for 300+ regulatory submissions, we provide proven capabilities to advance your programs with confidence.
